–
Lexeo Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−50.6
FY22:
−60.5
FY23:
−68.5
FY24:
−106
FY25:
−109
(positive)
Change from FY21 to FY25
millions USD
FY21:
−50.6
FY22:
−58.0
FY23:
−63.8
FY24:
−96.2
FY25:
−101
(positive)
Change from FY21 to FY25
millions USD
FY21:
−50.6
FY22:
−59.3
FY23:
−66.4
FY24:
−98.4
FY25:
−99.7
(positive)
Change from FY21 to FY25
millions USD
FY21:
−50.6
FY22:
−59.3
FY23:
−66.4
FY24:
−98.3
FY25:
−100.0
All amounts in millions USD FY21: figures supplemented from Twelve Data because the SEC filings do not reach back this far.